SGLT2 Inhibitors Market 2036 Outlook at USD 34.6 Billion, China - CAGR 8.4%, Germany - 7.1%, France - 6.5%
The SGLT2 inhibitors market is forecast to expand from USD 19 billion in 2026 to USD 34.6 billion by 2036, registering a 6.2% CAGR over the forecast period. Fact.MR attributes this expansion to the increasing prevalence of type 2 diabetes, growing demand for effective blood glucose management, and wider use of SGLT2 inhibitors in treating heart failure and chronic kidney disease. The market was...
0 Commenti 0 condivisioni 152 Views 0 Anteprima